|
Kuslima Tina Shogen founded Alfacell Corporation in 1981 to pursue research she initiated as a Development Biology student in the University Honors Program at Fairleigh Dickinson University (FDU). She has served as Chief Executive Officer of Alfacell since 1986, and Chairman of the Board of Directors since 1996. Prior to Alfacell, she was a Teaching Fellow and faculty member at FDU, the founder and president of a biomedical research consortium specializing in Good Laboratory Practices and animal toxicology, and a consultant for Lever Brothers. Dr. Shogen has received numerous awards for achievements in academia, science and industry, including the first-ever Pioneer Award from the Mesothelioma Applied Research Foundation and the FDU Pinnacle Award. She was also named to the inaugural PharmaVOICE 100 List of Most Inspiring People in the healthcare industry, and was one of only 27 CEO’s recognized. Dr. Shogen has authored numerous scientific papers and articles, been an invited presenter and panelist at several conferences, and served as the keynote speaker at The International Meeting on Ribonucleases on multiple occasions. Dr. Shogen earned a B.S., M.S. and D.Sc. from FDU. She is a Phi Beta Kappa graduate.
| 